ABSTRACT
Introduction
Selenium, an essential micronutrient, is a natural component of selenium dependent enzymes, and in most of these it occurs in the amino acid selenocysteine, that is present in the catalytic centers of the proteins [1] . These selenium dependent enzymes called selenoproteins include one or more Selenocysteine residues, where selenium acts an antioxidant [2] . Selenium plays an important role in the proper functioning of the immune system and inhibiting the progression of HIV infection to AIDS. It is required for the activity of the enzyme glutathione peroxidase, and deficiency in selenium may cause myopathy, cardiomyopathy and immune dysfunction [3] .
Selenoproteins such as glutathione peroxidases, thioredoxin reductases, and iodothyronine deiodinases are involved in redox reactions [4] . At the physiological level, these enzymes are involved in diverse metabolic and physiological functions ranging from antioxidant defense to fertility, muscle development and function, thyroid hormone metabolism, and immune function [5] .
Expression of the selenoproteins requires the incorporation and biosynthesis of the amino acid Selenocysteine (reviewed in Atkins & Gesteland, 2000) . Selenocysteine is the 21 st amino acid in the genetic code and is encoded by the codon UGA that is generally a termination codon. Certain factors have been found in eukaryotes that mediate the biosynthesis of Selenocysteine and thus the expression of selenoproteins [6, 7] . One of the major factor are the SECIS elements, an RNA structural motif, that have been found in the 3' UTR of the eukaryotic selenoprotein mRNA.
The 3' and 5' untranslated regions of the HIV-1 genome have all the RNA motifs concentrated within it, these include internal ribosome entry sites, packaging signals, pseudoknots, transfer RNA mimics, ribosomal frameshift motifs, and cis-regulatory elements [8, 9] . In the human immunodeficiency virus (HIV), RNA structures activate transcription, initiate reverse transcription, facilitate genomic dimerization, direct HIV packaging, manipulate reading frames, regulate RNA nuclear export, signal polyadenylation, and interact with viral and host proteins [9] [10] [11] [12] [13] . Most potential regulatory structures within the HIV-1 genome are uncharacterized raising the possibility of new RNA structure-mediated regulation to be identified [14] .
It has been reported that during HIV infection the level of selenium in the host, decreases and expression of viral selenoproteins increases. Also, it has been proposed that HIV-1 may encode several selenoproteins one of which has significant sequence similarity to GPx that is a mammalian selenoprotein [15] .
Selenocysteine insertion sequence (SECIS) element has not yet been identified in the HIV genome by either biologic or computational methods. Sequence analysis has identified locations in HIV-1 strain HXB2 where SECIS element could exist [16] .
The aim of this study is to identify the plausible SECIS elements in the HIV-1 genome and deduce their role in the deficiency of selenium and increased expression of viral selenoproteins during HIV infection.
The results obtained showed that, indeed there are SECIS elements present in the HIV-1 genome and the human Sec tRNA Sec binds to the viral selenoprotein mRNA, wherein possibly the key residues are the atoms of A8 and U9 which are involved in stability of the binding.
We hypothesize that during HIV infection when translation occurs, the human Selenocysteine tRNA Sec binds to the viral selenoprotein mRNA that has the presence of SECIS elements. Thus Selenocysteine would get incorporated in the growing polypeptide chain, utilizing the host's selenium, and will lead to the expression of viral selenoproteins instead of human selenoproteins.
Methods
We first retrieved 847 complete genome sequences of the HIV-1 genome from the NCBI database. The RNA regulatory motifs for all these sequences were then obtained using a stacking energy thermodynamic model based on Bayesian statistics for identifying the homologs of Regulatory RNA motifs and elements against an input mRNA sequence. The full process of a typical Bayesian analysis can be roughly described as consisting of three main steps: 1) setting up a full probability model that includes all the variables so as to capture the relation-ship among these variables; 2) summarizing the findings for particular interests by appropriate posterior distributions; 3) evaluating the appropriateness of the model and suggesting improvements [17] .
A standard procedure for carrying out step 1) is to first write down the likelihood function, i.e., the probability of the observed data given the unknowns, and multiply it by a prior distribution, i.e., a distribution for all the unobserved variables (typically unknown parameters). The joint probability is represented as joint = likelihood prior, i.e.,
where the prior distribution reveals what is known about the parameter without the knowledge of the data. Bayesian inference is drawn by examining the probability of all possible values of the parameter after considering the data. Accordingly, step 2) is completed by obtaining the posterior distribution:
where the posterior distribution tells us what is known about y given knowledge of the data. Both sequence homologs and structural homologs of regulatory RNA motifs could be identified. In this work the basic focus was on the RNA structural motif named SECIS (Selenocysteine Insertion Sequence) element.
Our next in-silico experiment was performed on the same set of HIV-1 genome sequences to specifically identify the SECIS elements, if present, in the genome. This was done using a computational tool based on a SECIS consensus model the key feature of which is a conserved guanosine in a small apical loop of the properly positioned structure [18] .
Using the sequences of the SECIS elements obtained, we designed their secondary structures based on the RNA secondary structure (folding) prediction algorithm given by M.Zuker. The algorithm predicts the possible secondary structures based on minimum free energy (∆G) criterion. We arranged the secondary structures according to increasing free energies (a negative quantity), and selected the first 20 which had the least free energy values.
As we had hypothesized, our next experiment was to see whether the human Selenocysteine tRNA binds to the viral selenoprotein mRNA. For this the tertiary structures of the above 20 secondary structures were designed using computational tools. Human selenocysteine tRNA sequence was obtained from NCBI and secondary structure is designed. The tertiary structure of human Selenocysteine tRNA was obtained from PDB (PDB id 3A3A). We then tried to dock them individually, i.e. we performed twenty dockings, with the 20 tertiary structures of SECIS elements as receptor and human Selenocysteine tRNA as the ligand.
In the last part of our work, we removed the residues A8 and U9 from the tertiary structure of human Selenocysteine tRNA and performed the dockings again. The new docking results were compared with the earlier docking results. This result thus confirmed putatively, to some extent, that SECIS elements may be present in the HIV genome. Other motifs were also obtained i.e. K-Box, GY-Box, Gamma interferon activated inhibitor of Ceruloplasmin mRNA translation (GAIT element), Brd-Box, Cytoplasmic polyadenylation element, Alcohol dehydrogenase 3'UTR down regulation control element (ADH_DRE), Mos polyadenylation response element (Mos-PRE), Androgen receptor CU-rich element (AR_CURE) in the 3' UTR and those in the 5' UTR are Terminal Oligo-pyrimidine Tract (TOP), Internal Ribosome Entry Site (IRES), Upstream Open Reading Frame (uORF).Exonic regulatory motifs, transcriptional regulatory motifs, miRNA target sites and RNA structural elements were also found, (see Table 2 ).
The presence of Selenocysteine insertion sequence (SECIS) elements has been confirmed in eukaryotes (including humans). In eukaryotes, SECIS elements are required for the expression of selenoproteins. Functional selenoproteins, similar to mammalian selenoproteins, have been found in the HIV-1 genome. Based on these already proven theories it was thought that, the HIV genome may contain SECIS elements and this was confirmed by performing a search for SECIS elements on all the 847 complete genome sequences of the HIV-1 genome. The number of SECIS elements obtained putatively was variable for each sequence. The total number of SECIS elements obtained was 3215.
Since lower free energy value means a highly stable structure, so out of the 3215 structures 25 most stable predicted structures were selected (see Figure 1) .
The sequence of Human selenocysteine tRNA was retrieved from PDB (>3A3A:A|PDBID|CHAIN|SEQUEN-CEGCCCGGAUGAUCCUCAGUGGUCUGGGGUGC-AGGCUUCAAACCUGUAGCUGUCUAGCGACAGA-GUGGUUCAAUUCCACCUUUCGGGCGCCA) and its corresponding secondary structure was designed by application of RNA covariance models, which are general, probabilistic secondary structure profiles based on stochastic context-free grammars (see Figure 2) . The tertiary structures of all the 20 SECIS elements showed a similar kind of a structure, (see Figure 3) .
These were docked to the crystal structure of human Selenocysteine tRNA (see Figure 4) .
Also known is the fact that during HIV infection selenium pool of the host gets depleted and viral selenoproteins increase. During translation, the tRNA binds to the mRNA (at the corresponding codon) for the expression of the protein. Human Selenocysteine tRNA (tRNA Sec ) has an anticodon complementary to the UGA codon. If the human Selenocysteine tRNA binds to the viral mRNA that has the SECIS elements, then the viral selenoproteins might get expressed and this may be the probable cause of the increase in viral selenoproteins and depletion of host selenium, as it is being used up by the viral genome. So, the human Selenocysteine tRNA, instead of getting attached to its own selenoprotein mRNA, attaches to the viral selenoprotein mRNA during HIV infection. The docking results confirmed this putatively as the free energy values of the 20 docked complexes (see Figure 5) were very low, hence the binding was highly stable. The docked complexes were clustered according to E-values and country ( Table 3) .
The D stem and the extra arm do not form tertiary in- teractions in tRNA Sec . Rather, tRNA Sec has an open cavity, in place of the tertiary core of a canonical tRNA. The linker residues, A8 and U9, connecting the acceptor and D stems, are not involved in tertiary base pairing. Instead, U9 is stacked on the first base pair of the extra arm. These features might allow tRNA Sec to be the target of the Selenocysteine synthesis/incorporation machineries. Following this finding, the residues A8 and U9 were removed from the structure of human selenocysteine tRNA and this was docked with the SECIS element (one from Group-3).The atoms of the residues have been highlighted (see Figure 6 ) and the bond between the SECIS lement and the residues is shown (see Figure 7) . e The result showed an increase in the E-value i.e. the free energy, hence a less stable structure than was obtained earlier (see Figure 8) .
It shows that the residues A8 and U9 in the open cav- ity are an important part of the stable binding of the human Sec tRNA Sec and HIV SECIS elements.
